BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21075102)

  • 21. The effect of nitric oxide, growth factors, and estrogen on gastric cell migration.
    Nylander-Koski O; Kiviluoto T; Puolakkainen P; Kivilaakso E; Mustonen H
    J Surg Res; 2007 Dec; 143(2):230-7. PubMed ID: 17950324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor and Madin-Darby canine kidney cells: in vitro models of epithelial cell movement and morphogenesis.
    Balkovetz DF
    Microsc Res Tech; 1998 Dec; 43(5):456-63. PubMed ID: 9858342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of epithelial-mesenchymal transition by transforming growth factor β.
    Moustakas A; Heldin CH
    Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion.
    Davies G; Jiang WG; Mason MD
    Clin Cancer Res; 2001 Oct; 7(10):3289-97. PubMed ID: 11595727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-mesenchymal transition in ovarian cancer.
    Vergara D; Merlot B; Lucot JP; Collinet P; Vinatier D; Fournier I; Salzet M
    Cancer Lett; 2010 May; 291(1):59-66. PubMed ID: 19880243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of hepatocyte growth factor and epidermal growth factor on motility, morphology, mitogenesis, and signal transduction of primary rat hepatocytes.
    Stolz DB; Michalopoulos GK
    J Cell Biochem; 1994 Aug; 55(4):445-64. PubMed ID: 7962176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
    Cicchini C; Laudadio I; Citarella F; Corazzari M; Steindler C; Conigliaro A; Fantoni A; Amicone L; Tripodi M
    Exp Cell Res; 2008 Jan; 314(1):143-52. PubMed ID: 17949712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
    Yoshida GJ; Saya H
    Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of EMT by TGFβ in cancer.
    Heldin CH; Vanlandewijck M; Moustakas A
    FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HGF-induced DU145 cell scatter assay.
    Fram ST; Wells CM; Jones GE
    Methods Mol Biol; 2011; 769():31-40. PubMed ID: 21748667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Encounter of cancer cells with bone. Epithelial-mesenchymal transition in cancer].
    Horiguchi K; Saitoh M
    Clin Calcium; 2011 Mar; 21(3):405-10. PubMed ID: 21358062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth factors in induction of epithelial-mesenchymal transition and metastasis.
    Said NA; Williams ED
    Cells Tissues Organs; 2011; 193(1-2):85-97. PubMed ID: 21051862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Epithelial-to-Mesenchymal Transition Using Biomimetic Fibrous Scaffolds.
    Ravikrishnan A; Ozdemir T; Bah M; Baskerville KA; Shah SI; Rajasekaran AK; Jia X
    ACS Appl Mater Interfaces; 2016 Jul; 8(28):17915-26. PubMed ID: 27322677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.
    Siddiqui-Jain A; Hoj JP; Hargiss JB; Hoj TH; Payne CJ; Ritchie CA; Herron SR; Quinn C; Schuler JT; Hansen MDH
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3992-4000. PubMed ID: 28780159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor ecosystem regulates the roads for invasion and metastasis.
    Hendrix A; Gespach C; Bracke M; De Wever O
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):714-9. PubMed ID: 21676670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.